Bridgewater Associates’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVA
DCP
RF
VBA
RP
Bridgewater Associates's PRVA Position: Q2 2026 in Review
Bridgewater Associates sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 237,948 shares — an estimated $4.89M sold.
Bridgewater Associates first reported a position in PRVA in Q3 2021 and held it in 17 quarters. The position peaked at $4.98M in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.
- Bridgewater Associates reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
- Bridgewater Associates sold 237,948 Privia Health shares in Q2 2026, an estimated $4.89M.
- Bridgewater Associates first reported a position in Privia Health in Q3 2021 and held it in 17 quarters.
- Bridgewater Associates's Privia Health position peaked at $4.98M in Q4 2025.
- 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.